Xuezhi Hao
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Cancer Research top 10%
- Epidemiology
- Topics
- Lung Cancer Treatments and Mutations (91 papers)Lung Cancer Research Studies (54 papers)Lung Cancer Diagnosis and Treatment (28 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Xuezhi Hao
111 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 73
- Oncology 733
- Pulmonary and Respiratory Medicine 690
- Molecular Biology 372
- Cancer Research 216
- Epidemiology 130
Countries citing papers authored by Xuezhi Hao
This map shows the geographic impact of Xuezhi Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuezhi Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuezhi Hao more than expected).
Fields of papers citing papers by Xuezhi Hao
This network shows the impact of papers produced by Xuezhi Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuezhi Hao. The network helps show where Xuezhi Hao may publish in the future.
Co-authorship network of co-authors of Xuezhi Hao
This figure shows the co-authorship network connecting the top 25 collaborators of Xuezhi Hao. A scholar is included among the top collaborators of Xuezhi Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuezhi Hao. Xuezhi Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 8 | |
| 6 | 7 | |
| 7 | Efficacy of Osimertinib After Progression of First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) in EGFR-Mutated Lung Adenocarcinoma: A Real-World Study in Chinese Patients | 3 |
| 8 | 24 | |
| 9 | 2 | |
| 10 | 5 | |
| 11 | 13 | |
| 12 | 32 | |
| 13 | 4 | |
| 14 | 29 | |
| 15 | 53 | |
| 16 | 20 | |
| 17 | 8 | |
| 18 | 8 | |
| 19 | 5 | |
| 20 | 1 |
About Xuezhi Hao
Xuezhi Hao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 114 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (91 papers), Lung Cancer Research Studies (54 papers) and Lung Cancer Diagnosis and Treatment (28 papers). The work is most often cited by research in Oncology (733 citations), Pulmonary and Respiratory Medicine (690 citations) and Cancer Research (216 citations). Xuezhi Hao has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Junling Li, Puyuan Xing, Yan Wang, Xingsheng Hu, Yuxin Mu, Yutao Liu, Haiyan Xu, Ziyi Xu, Yuankai Shi and Shouzheng Wang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.